The great debate at “Immunotherapy Bridge 2018”, Naples, November 29th, 2018

As part of the 2018 Immunotherapy Bridge congress (November 28–29, Naples, Italy), the Great Debate session featured counterpoint views from leading experts on four topical clinical issues in immunotherapy today. These were: the relative importance of adaptive versus innate immunity in the anti-canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ascierto, Paolo A., Butterfield, Lisa H., Demaria, Sandra, Ferris, Robert L., Freeman, Gordon J., Lo, Roger S., Mantovani, Alberto, Nathan, Paul, Hamid, Omid, Politi, Katerina, Puzanov, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696687/
https://www.ncbi.nlm.nih.gov/pubmed/31416487
http://dx.doi.org/10.1186/s40425-019-0683-0
Descripción
Sumario:As part of the 2018 Immunotherapy Bridge congress (November 28–29, Naples, Italy), the Great Debate session featured counterpoint views from leading experts on four topical clinical issues in immunotherapy today. These were: the relative importance of adaptive versus innate immunity in the anti-cancer immune response; the merits of combination versus sequential immunotherapy regimens in the treatment of cancer; the advantages and disadvantages of murine models of cancer versus humans in order to evaluate immunotherapy; and whether or not mechanisms of resistance to immunotherapy differ between different cancers. Discussion of these important topics are summarised in this report.

Ejemplares similares